chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site extravasation, Injection site pruritus, Injection site swelling
Clinical narrative: swelling, like a bump, redness and itchiness at the injection site; swelling, like a bump, redness and itchiness at the injection site; swelling, like a bump, redness and itchiness at the injection site; as the vaccine provider remove the needle from the arm, they felt some liquid running down their arm; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE EXTRAVASATION (as the vaccine provider remove the needle from the arm, they felt some liquid running down their arm), INJECTION SITE PRURITUS (swelling, like a bump, redness and itchiness at the injection site), INJECTION SITE SWELLING (swelling, like a bump, redness and itchiness at the injection site) and INJECTION SITE ERYTHEMA (swelling, like a bump, redness and itchiness at the injection site) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination.     Concomitant products included type 1 diabetes oral medication and hypothyroidism oral medication for an unknown indication.    On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Feb-2021, the patient experienced INJECTION SITE EXTRAVASATION (as the vaccine provider remove the needle from the arm, they felt some liquid running down their arm). On an unknown date, the patient experienced INJECTION SITE PRURITUS (swelling, like a bump, redness and itchiness at the injection site), INJECTION SITE SWELLING (swelling, like a bump, redness and itchiness at the injection site) and INJECTION SITE ERYTHEMA (swelling, like a bump, redness and itchiness at the injection site). On 02-Feb-2021, INJECTION SITE EXTRAVASATION (as the vaccine provider remove the needle from the arm, they felt some liquid running down their arm) had resolved. At the time of the report, INJECTION SITE PRURITUS (swelling, like a bump, redness and itchiness at the injection site), INJECTION SITE SWELLING (swelling, like a bump, redness and itchiness at the injection site) and INJECTION SITE ERYTHEMA (swelling, like a bump, redness and itchiness at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Vaccination site pain
Clinical narrative: Arm is sore; Little tired; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Arm is sore) and FATIGUE (Little tired) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (Arm is sore) and FATIGUE (Little tired). At the time of the report, VACCINATION SITE PAIN (Arm is sore) and FATIGUE (Little tired) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.  No treatment information was provided.   This case was linked to US-MODERNATX, INC.-MOD-2021-023993 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-023993:Crosslinked (MOD21-022232)
Age: 91.0
Sex: U
Vaccine: COVID19
Symptoms: Asthenia, Pain in extremity
Clinical narrative: feeling very weak; slightly sore arm; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (feeling very weak) and PAIN IN EXTREMITY (slightly sore arm) in a 91-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A-72021) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included WARFARIN, FINASTERIDE, CHLORIDE, FUROSEMIDE, POTASSIUM CHLORIDE (LASIX + K) and emuferel for an unknown indication.    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ASTHENIA (feeling very weak) and PAIN IN EXTREMITY (slightly sore arm). At the time of the report, ASTHENIA (feeling very weak) and PAIN IN EXTREMITY (slightly sore arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Reporter did not allow further contact
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041220A) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Jan-2021, the patient experienced PAIN IN EXTREMITY (sore arm). The patient was treated with PARACETAMOL (TYLENOL) for Pain in arm, at an unspecified dose and frequency and IBUPROFEN for Pain in arm, at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (sore arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site induration, Vaccination site warmth
Clinical narrative: Warm to touch; Harder than rest of my arm; Red; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Warm to touch), VACCINATION SITE INDURATION (Harder than rest of my arm) and VACCINATION SITE ERYTHEMA (Red) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included HYDROCHLOROTHIAZIDE, ROSUVASTATIN and NEBIVOLOL HYDROCHLORIDE (BYSTOLIC) for an unknown indication.    On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Feb-2021, the patient experienced VACCINATION SITE WARMTH (Warm to touch), VACCINATION SITE INDURATION (Harder than rest of my arm) and VACCINATION SITE ERYTHEMA (Red). At the time of the report, VACCINATION SITE WARMTH (Warm to touch), VACCINATION SITE INDURATION (Harder than rest of my arm) and VACCINATION SITE ERYTHEMA (Red) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment medication was not provided by the reporter.   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 12-Jul-2021: Significant follow-up received included information about outcome of the events and was updated to recovered.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Pruritus, Urticaria
Clinical narrative: very very itchy; red and all over; hives; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (hives), PRURITUS (very very itchy) and ERYTHEMA (red and all over) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination.     Concurrent medical conditions included Hives (The day before vaccination,  01Feb2021, patient had eaten a cereal and had developed hives (patient said it was itchy but in a scale 1-10 it was a 2)) since 01-Feb-2021.    On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Feb-2021, the patient experienced URTICARIA (hives). On 02-Feb-2021, the patient experienced PRURITUS (very very itchy) and ERYTHEMA (red and all over). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) ongoing since an unknown date for Hives, at an unspecified dose and frequency and IBUPROFEN ongoing since an unknown date for Hives, at an unspecified dose and frequency. At the time of the report, URTICARIA (hives), PRURITUS (very very itchy) and ERYTHEMA (red and all over) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test, SARS-CoV-2 test positive
Clinical narrative: tested positive for covid-19; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of SARS-COV-2 TEST POSITIVE (tested positive for covid-19) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Feb-2021, the patient experienced SARS-COV-2 TEST POSITIVE (tested positive for covid-19). The patient was treated with BAMLANIVIMAB for Adverse event, at a dose of UNK dosage form. At the time of the report, SARS-COV-2 TEST POSITIVE (tested positive for covid-19) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 01-Feb-2021, SARS-CoV-2 test: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 31.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Back pain, Cough, Myalgia, Ocular hyperaemia
Clinical narrative: Lower back ache; Coughing; Blood shot eyes; Small amount of swelling on upper arm; Running  nose; Joint aches; Muscle aches; Pain around injection site; Soreness in arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Soreness in arm), BACK PAIN (Lower back ache), COUGH (Coughing), OCULAR HYPERAEMIA (Blood shot eyes) and PERIPHERAL SWELLING (Small amount of swelling on upper arm) in a 31-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 (tested positive for COVID) on 23-Dec-2020.   On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Jan-2021, the patient experienced PAIN IN EXTREMITY (Soreness in arm) and VACCINATION SITE PAIN (Pain around injection site). On 27-Jan-2021, the patient experienced BACK PAIN (Lower back ache), COUGH (Coughing), OCULAR HYPERAEMIA (Blood shot eyes), PERIPHERAL SWELLING (Small amount of swelling on upper arm), RHINORRHOEA (Running  nose), ARTHRALGIA (Joint aches) and MYALGIA (Muscle aches). At the time of the report, PAIN IN EXTREMITY (Soreness in arm), BACK PAIN (Lower back ache), COUGH (Coughing), OCULAR HYPERAEMIA (Blood shot eyes), PERIPHERAL SWELLING (Small amount of swelling on upper arm), RHINORRHOEA (Running  nose), ARTHRALGIA (Joint aches), MYALGIA (Muscle aches) and VACCINATION SITE PAIN (Pain around injection site) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 23-Dec-2020, SARS-CoV-2 test positive: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.  Treatment medications were not provided.
Age: 31.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity, Peripheral swelling, Rhinorrhoea, SARS-CoV-2 test positive, Vaccination site pain
Clinical narrative: Lower back ache; Coughing; Blood shot eyes; Small amount of swelling on upper arm; Running  nose; Joint aches; Muscle aches; Pain around injection site; Soreness in arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Soreness in arm), BACK PAIN (Lower back ache), COUGH (Coughing), OCULAR HYPERAEMIA (Blood shot eyes) and PERIPHERAL SWELLING (Small amount of swelling on upper arm) in a 31-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 (tested positive for COVID) on 23-Dec-2020.   On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Jan-2021, the patient experienced PAIN IN EXTREMITY (Soreness in arm) and VACCINATION SITE PAIN (Pain around injection site). On 27-Jan-2021, the patient experienced BACK PAIN (Lower back ache), COUGH (Coughing), OCULAR HYPERAEMIA (Blood shot eyes), PERIPHERAL SWELLING (Small amount of swelling on upper arm), RHINORRHOEA (Running  nose), ARTHRALGIA (Joint aches) and MYALGIA (Muscle aches). At the time of the report, PAIN IN EXTREMITY (Soreness in arm), BACK PAIN (Lower back ache), COUGH (Coughing), OCULAR HYPERAEMIA (Blood shot eyes), PERIPHERAL SWELLING (Small amount of swelling on upper arm), RHINORRHOEA (Running  nose), ARTHRALGIA (Joint aches), MYALGIA (Muscle aches) and VACCINATION SITE PAIN (Pain around injection site) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 23-Dec-2020, SARS-CoV-2 test positive: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.  Treatment medications were not provided.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Chills, Diarrhoea, Nausea, Vomiting
Clinical narrative: diarrhea; weakness; vomiting; shivering/chills 3-4 hours; nauseous; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (diarrhea), ASTHENIA (weakness), VOMITING (vomiting), CHILLS (shivering/chills 3-4 hours) and NAUSEA (nauseous) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, the patient experienced DIARRHOEA (diarrhea), ASTHENIA (weakness), VOMITING (vomiting), CHILLS (shivering/chills 3-4 hours) and NAUSEA (nauseous). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE, PARACETAMOL (TYLENOL PM) for Adverse event, at an unspecified dose and frequency. At the time of the report, DIARRHOEA (diarrhea), ASTHENIA (weakness), VOMITING (vomiting), CHILLS (shivering/chills 3-4 hours) and NAUSEA (nauseous) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.   Reporter did not allow further contact
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pain, Vaccination site pruritus, Vaccination site rash, Vaccination site swelling
Clinical narrative: Itching at the injection site; Reaction of a rash; Redness at the injection site; Swollen injection site; Tender to the touch injection site; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE PRURITUS (Itching at the injection site), VACCINATION SITE RASH (Reaction of a rash), VACCINATION SITE SWELLING (Swollen injection site), VACCINATION SITE PAIN (Tender to the touch injection site) and VACCINATION SITE ERYTHEMA (Redness at the injection site) in an 85-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043L20A) for COVID-19 vaccination.     Concurrent medical conditions included Drug allergy (to sulfur) and Penicillin allergy. Concomitant products included LISINOPRIL, LEVOTHYROXINE, RIVAROXABAN (XARELTO), METOPROLOL TARTRATE, VITAMIN D3 and CALCIUM for an unknown indication.    On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Jan-2021, the patient experienced VACCINATION SITE SWELLING (Swollen injection site) and VACCINATION SITE PAIN (Tender to the touch injection site). On 03-Feb-2021, the patient experienced VACCINATION SITE PRURITUS (Itching at the injection site), VACCINATION SITE RASH (Reaction of a rash) and VACCINATION SITE ERYTHEMA (Redness at the injection site). The patient was treated with LORATADINE (oral) ongoing since an unknown date for Itching, at a dose of 1 dosage form every 24 hours. At the time of the report, VACCINATION SITE PRURITUS (Itching at the injection site) had resolved and VACCINATION SITE RASH (Reaction of a rash), VACCINATION SITE SWELLING (Swollen injection site), VACCINATION SITE PAIN (Tender to the touch injection site) and VACCINATION SITE ERYTHEMA (Redness at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Tenderness
Clinical narrative: tiredness; tender arm; This spontaneous case was reported by a consumer and describes the occurrence of TENDERNESS (tender arm) and FATIGUE (tiredness) in an 80-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038K20A) for COVID-19 vaccination.     Concurrent medical conditions included Cancer.    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Jan-2021, the patient experienced TENDERNESS (tender arm). On an unknown date, the patient experienced FATIGUE (tiredness). On 28-Jan-2021, TENDERNESS (tender arm) had resolved. At the time of the report, FATIGUE (tiredness) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.  No treatment information was provided.   This case was linked to US-MODERNATX, INC.-MOD-2021-016013 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 28-Jun-2021: Event added , relevant history added.; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-016013:Crosslinked (MOD21-020670)
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Ageusia, Anosmia, Fatigue, Nasal congestion, SARS-CoV-2 test
Clinical narrative: loss of smell; loss of taste; congestion; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of ANOSMIA (loss of smell), AGEUSIA (loss of taste), NASAL CONGESTION (congestion) and FATIGUE (fatigue) in a 34-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Jan-2021, the patient experienced ANOSMIA (loss of smell), AGEUSIA (loss of taste), NASAL CONGESTION (congestion) and FATIGUE (fatigue). At the time of the report, ANOSMIA (loss of smell), AGEUSIA (loss of taste), NASAL CONGESTION (congestion) and FATIGUE (fatigue) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 26-Jan-2021, SARS-CoV-2 test: negative (Negative) Patient tested negative twice.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment medications were reported.
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Anogenital warts, Pain in extremity, Pyrexia, Tongue pigmentation, Vaccination site erythema
Clinical narrative: looks like Condyloma or inflamed taste bud; m Redness at injection site; Tiny white spot that has grown under her tongue; Soreness of arm; pyrexia; This spontaneous case was reported by a consumer and describes the occurrence of ANOGENITAL WARTS (looks like Condyloma or inflamed taste bud), TONGUE PIGMENTATION (Tiny white spot that has grown under her tongue), PAIN IN EXTREMITY (Soreness of arm), PYREXIA (pyrexia) and VACCINATION SITE ERYTHEMA (m Redness at injection site) in a 24-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 02-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 02-Feb-2021, the patient experienced PYREXIA (pyrexia). On 03-Feb-2021, the patient experienced TONGUE PIGMENTATION (Tiny white spot that has grown under her tongue) and PAIN IN EXTREMITY (Soreness of arm). On 04-Feb-2021, the patient experienced VACCINATION SITE ERYTHEMA (m Redness at injection site). On 05-Feb-2021, the patient experienced ANOGENITAL WARTS (looks like Condyloma or inflamed taste bud). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event following immunization, at an unspecified dose and frequency. At the time of the report, ANOGENITAL WARTS (looks like Condyloma or inflamed taste bud), TONGUE PIGMENTATION (Tiny white spot that has grown under her tongue), PAIN IN EXTREMITY (Soreness of arm), PYREXIA (pyrexia) and VACCINATION SITE ERYTHEMA (m Redness at injection site) outcome was unknown.            No relevant concomitant medications were reported
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Asymptomatic COVID-19, SARS-CoV-2 test positive
Clinical narrative: Asymptomatic Covid-19; This spontaneous case was reported by a consumer and describes the occurrence of ASYMPTOMATIC COVID-19 (Asymptomatic Covid-19) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Jan-2021, the patient experienced ASYMPTOMATIC COVID-19 (Asymptomatic Covid-19). At the time of the report, ASYMPTOMATIC COVID-19 (Asymptomatic Covid-19) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 25-Jan-2021, SARS-CoV-2 test positive: Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.; Sender's Comments: Based on the mechanism of action of mRNA -1273 vaccine, the event is assessed as unlikely related to mRNA-1273.
Sex: M
Vaccine: COVID19
Symptoms: Influenza like illness
Clinical narrative: Flu like symptoms 8-9 hours after injection; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu like symptoms 8-9 hours after injection) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     Concurrent medical conditions included No adverse event.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INFLUENZA LIKE ILLNESS (Flu like symptoms 8-9 hours after injection). At the time of the report, INFLUENZA LIKE ILLNESS (Flu like symptoms 8-9 hours after injection) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication list was not provided. Treatment information was not provided.   Reporter did not allow further contact
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Contusion, Mass, Pruritus, Rash, Skin warm
Clinical narrative: Little bit of itching; Bruise on the center; Lump on her skin; skin Warm; Rash grew to 3 to 4 inches and going around the arm (spreading); Little rash; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PRURITUS (Little bit of itching), CONTUSION (Bruise on the center), MASS (Lump on her skin), SKIN WARM (skin Warm) and RASH (Little rash) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history reported.  Concomitant products included TRAMADOL for an unknown indication.   On 23-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Jan-2021, the patient experienced RASH (Little rash). On 30-Jan-2021, the patient experienced PRURITUS (Little bit of itching), CONTUSION (Bruise on the center), MASS (Lump on her skin), SKIN WARM (skin Warm) and RASH (Rash grew to 3 to 4 inches and going around the arm (spreading)). On 26-Jan-2021, RASH (Little rash) had resolved. At the time of the report, PRURITUS (Little bit of itching), CONTUSION (Bruise on the center), MASS (Lump on her skin), SKIN WARM (skin Warm) and RASH (Rash grew to 3 to 4 inches and going around the arm (spreading)) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information provided included acetaminophen.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Maternal exposure during pregnancy, Pregnancy test, Ultrasound foetal
Clinical narrative: Pregnant; This spontaneous prospective pregnancy case was reported by a patient and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (Pregnant) in a 32-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination.     Concurrent medical conditions included Allergy (Nitrous oxide allergy), Grass allergy, Seasonal allergy (trees allergy), Asthma (since childhood.) and Anxiety disorder since 09-Jan-2019. Concomitant products included ALBUTEROL [SALBUTAMOL] for Asthma, FLUOXETINE HYDROCHLORIDE (PROZAC) for Generalized anxiety disorder, DOXYLAMINE SUCCINATE (UNISOM [DOXYLAMINE SUCCINATE]) for Nausea, ACETYLSALICYLIC ACID (ASPIRIN 81) for Pregnancy, ESOMEPRAZOLE MAGNESIUM (NEXIUM [ESOMEPRAZOLE MAGNESIUM]), FOLIC ACID, VITAMIN B12 NOS and MINERALS NOS, VITAMINS NOS (PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]) for an unknown indication.    On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on 15-Aug-2020 and the estimated date of delivery was 10-Jun-2021. On 14-Jan-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Pregnant). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  twenty-first week of the pregnancy. The delivery occurred on an unknown date, which was reported as Unknown. For neonate 1, The outcome was reported as Unknown. On 14-Jan-2021, MATERNAL EXPOSURE DURING PREGNANCY (Pregnant) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 01-Oct-2020, Pregnancy test: positive (Positive) Positive. On 25-Nov-2020, Ultrasound foetal: normal (normal) Normal.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Genetic testing done on 25 Nov 2020, Normal. Anatomy scan was done on 19 Jan 2021 (results not reported). Treatment medications were not reported.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Hypersomnia, Myalgia
Clinical narrative: she had a terrible reaction to the 1st shot; Fever; Fatigue; Headache; Muscle pain; Chills; Vomited; Slept for 36 hrs; This spontaneous case was reported by a consumer and describes the occurrence of HYPERSOMNIA (Slept for 36 hrs), VACCINATION COMPLICATION (she had a terrible reaction to the 1st shot), PYREXIA (Fever), FATIGUE (Fatigue) and HEADACHE (Headache) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Immunoglobulins decreased (Immunoglobulins deficiency). Concomitant products included IMMUNOGLOBULIN G HUMAN (IGG) for an unknown indication.    On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jan-2021, the patient experienced HYPERSOMNIA (Slept for 36 hrs), PYREXIA (Fever), FATIGUE (Fatigue), HEADACHE (Headache), MYALGIA (Muscle pain), CHILLS (Chills) and VOMITING (Vomited). On an unknown date, the patient experienced VACCINATION COMPLICATION (she had a terrible reaction to the 1st shot). At the time of the report, HYPERSOMNIA (Slept for 36 hrs), VACCINATION COMPLICATION (she had a terrible reaction to the 1st shot), PYREXIA (Fever), FATIGUE (Fatigue), HEADACHE (Headache), MYALGIA (Muscle pain), CHILLS (Chills) and VOMITING (Vomited) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment medication reported was Tylenol, but patient was unsure if she actually took it. PCP advised that she should be woken up frequently to drink water.   This case was linked to MOD-2021-250729 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 07-Jul-2021: Updated information of one new adverse event, medical history and reporter contact details are added.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Vaccination complication, Vomiting
Clinical narrative: she had a terrible reaction to the 1st shot; Fever; Fatigue; Headache; Muscle pain; Chills; Vomited; Slept for 36 hrs; This spontaneous case was reported by a consumer and describes the occurrence of HYPERSOMNIA (Slept for 36 hrs), VACCINATION COMPLICATION (she had a terrible reaction to the 1st shot), PYREXIA (Fever), FATIGUE (Fatigue) and HEADACHE (Headache) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Immunoglobulins decreased (Immunoglobulins deficiency). Concomitant products included IMMUNOGLOBULIN G HUMAN (IGG) for an unknown indication.    On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jan-2021, the patient experienced HYPERSOMNIA (Slept for 36 hrs), PYREXIA (Fever), FATIGUE (Fatigue), HEADACHE (Headache), MYALGIA (Muscle pain), CHILLS (Chills) and VOMITING (Vomited). On an unknown date, the patient experienced VACCINATION COMPLICATION (she had a terrible reaction to the 1st shot). At the time of the report, HYPERSOMNIA (Slept for 36 hrs), VACCINATION COMPLICATION (she had a terrible reaction to the 1st shot), PYREXIA (Fever), FATIGUE (Fatigue), HEADACHE (Headache), MYALGIA (Muscle pain), CHILLS (Chills) and VOMITING (Vomited) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment medication reported was Tylenol, but patient was unsure if she actually took it. PCP advised that she should be woken up frequently to drink water.   This case was linked to MOD-2021-250729 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 07-Jul-2021: Updated information of one new adverse event, medical history and reporter contact details are added.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Blister, Mass, Rash, Rash pruritic
Clinical narrative: rash spread the right wrist and began to blister; Rash spots were very itchy; rash spread to under breast about 2x2 inches/under right wrist; Raised bump on back/under armpit; This spontaneous case was reported by a consumer and describes the occurrence of MASS (Raised bump on back/under armpit), BLISTER (rash spread the right wrist and began to blister), RASH PRURITIC (Rash spots were very itchy) and RASH (rash spread to under breast about 2x2 inches/under right wrist) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004M204) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Feb-2021, the patient experienced MASS (Raised bump on back/under armpit). On 02-Feb-2021, the patient experienced RASH (rash spread to under breast about 2x2 inches/under right wrist). On 04-Feb-2021, the patient experienced BLISTER (rash spread the right wrist and began to blister) and RASH PRURITIC (Rash spots were very itchy). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency and HYDROCORTISONE at an unspecified dose and frequency. At the time of the report, MASS (Raised bump on back/under armpit), BLISTER (rash spread the right wrist and began to blister), RASH PRURITIC (Rash spots were very itchy) and RASH (rash spread to under breast about 2x2 inches/under right wrist) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.    Most recent FOLLOW-UP information incorporated above includes: On 20-Apr-2021: 20-APR-2021:only reporter address was updated
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Pyrexia
Clinical narrative: Dizziness; Fever; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness) and PYREXIA (Fever) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004M20A) for COVID-19 vaccination.     The patient's past medical history included Surgery (surgery on throat) on 20-Apr-2021.   On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 05-Feb-2021, the patient experienced DIZZINESS (Dizziness) and PYREXIA (Fever). The patient was treated with PARACETAMOL (TYLENOL) at a dose of UNK dosage form. On 05-Feb-2021, DIZZINESS (Dizziness) and PYREXIA (Fever) had resolved.            No Concomitant medications were reported. No Treatment information was reported.   Most recent FOLLOW-UP information incorporated above includes: On 20-Apr-2021: Address of the reporter was added, patient age was added, pregnancy status was added as NO, first and second  dose start date was added, Event was added with start and stop date On 12-Jul-2021: Follow-up information received on 12-JUL-2021; Events stop date and outcome updated.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling cold, Headache, Pyrexia
Clinical narrative: feeling cold; fever; very bad severe headache; This spontaneous case was reported by a consumer and describes the occurrence of FEELING COLD (feeling cold), PYREXIA (fever) and HEADACHE (very bad severe headache) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination.     No medical history was reported.  Concomitant products included VITAMINS NOS for an unknown indication.    On 01-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Feb-2021, the patient experienced PYREXIA (fever) and HEADACHE (very bad severe headache). On 05-Feb-2021, the patient experienced FEELING COLD (feeling cold). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, FEELING COLD (feeling cold), PYREXIA (fever) and HEADACHE (very bad severe headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       On 07-Feb-2021, the patient reported another episode of headache.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Eye swelling, Oedema peripheral, Pruritus, Rash
Clinical narrative: SWOLLEN EYES; ITCHINESS; EDEMA of legs; RASH on face and legs; This spontaneous case was reported by a consumer and describes the occurrence of EYE SWELLING (SWOLLEN EYES), PRURITUS (ITCHINESS), OEDEMA PERIPHERAL (EDEMA of legs) and RASH (RASH on face and legs) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Jan-2021, the patient experienced EYE SWELLING (SWOLLEN EYES), PRURITUS (ITCHINESS), OEDEMA PERIPHERAL (EDEMA of legs) and RASH (RASH on face and legs). At the time of the report, EYE SWELLING (SWOLLEN EYES), PRURITUS (ITCHINESS), OEDEMA PERIPHERAL (EDEMA of legs) and RASH (RASH on face and legs) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. Patient reported using diphenhydramine for treating her symptoms.
Sex: F
Vaccine: COVID19
Symptoms: Illness
Clinical narrative: sickness; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (sickness) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ILLNESS (sickness). At the time of the report, ILLNESS (sickness) outcome was unknown. Not Provided          No relevant concomitant medications were provided. No treatment information was provided.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Sneezing, Stomatitis, Throat irritation
Clinical narrative: tickle in the throat/couldn't talk; sneezed 2 or 4 times a day; roof of the mouth was rough and puffy; This spontaneous case was reported by a consumer and describes the occurrence of THROAT IRRITATION (tickle in the throat/couldn't talk), SNEEZING (sneezed 2 or 4 times a day) and STOMATITIS (roof of the mouth was rough and puffy) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported).    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 31-Jan-2021, the patient experienced THROAT IRRITATION (tickle in the throat/couldn't talk), SNEEZING (sneezed 2 or 4 times a day) and STOMATITIS (roof of the mouth was rough and puffy). At the time of the report, THROAT IRRITATION (tickle in the throat/couldn't talk), SNEEZING (sneezed 2 or 4 times a day) and STOMATITIS (roof of the mouth was rough and puffy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant information provided. No treatment information provided.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of these events, a causal relationship cannot be excluded.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Skin discolouration, Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling, Vaccination site warmth
Clinical narrative: Skin is very little pinkish; Hot to touch at the site of injection; Itching; Redness; Swelling; This spontaneous case was reported by a patient (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE WARMTH (Hot to touch at the site of injection), VACCINATION SITE PRURITUS (Itching), VACCINATION SITE ERYTHEMA (Redness), VACCINATION SITE SWELLING (Swelling) and SKIN DISCOLOURATION (Skin is very little pinkish) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination.     The patient's past medical history included Anaphylactic reaction to vaccine (to vaccine). Concomitant products included METFORMIN for an unknown indication.    On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Jan-2021, the patient experienced VACCINATION SITE WARMTH (Hot to touch at the site of injection), VACCINATION SITE PRURITUS (Itching), VACCINATION SITE ERYTHEMA (Redness) and VACCINATION SITE SWELLING (Swelling). On an unknown date, the patient experienced SKIN DISCOLOURATION (Skin is very little pinkish). At the time of the report, VACCINATION SITE WARMTH (Hot to touch at the site of injection), VACCINATION SITE PRURITUS (Itching), VACCINATION SITE ERYTHEMA (Redness) and VACCINATION SITE SWELLING (Swelling) outcome was unknown and SKIN DISCOLOURATION (Skin is very little pinkish) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient was advised diphenhydramine by her physician for itchiness, but she did not take it.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Grip strength decreased, Hypoaesthesia, Injection site rash, Myalgia
Clinical narrative: Tingling in the arms and fingers; Numbness; No strength in the arms; Cannot grip things; Soreness and redness in the arm; Rash at injection site; Felt like throwing up; This spontaneous case was reported by a consumer and describes the occurrence of NAUSEA (Felt like throwing up), PARAESTHESIA (Tingling in the arms and fingers), MYALGIA (Soreness and redness in the arm), HYPOAESTHESIA (Numbness) and ASTHENIA (No strength in the arms) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037K20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced NAUSEA (Felt like throwing up), PARAESTHESIA (Tingling in the arms and fingers), MYALGIA (Soreness and redness in the arm), HYPOAESTHESIA (Numbness), ASTHENIA (No strength in the arms), GRIP STRENGTH DECREASED (Cannot grip things) and INJECTION SITE RASH (Rash at injection site). The patient was treated with LORATADINE, PSEUDOEPHEDRINE HYDROCHLORIDE (BENADRYL 24 D) for Adverse event, at a dose of UNK dosage form. At the time of the report, NAUSEA (Felt like throwing up), PARAESTHESIA (Tingling in the arms and fingers), MYALGIA (Soreness and redness in the arm), HYPOAESTHESIA (Numbness), ASTHENIA (No strength in the arms), GRIP STRENGTH DECREASED (Cannot grip things) and INJECTION SITE RASH (Rash at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient received acupuncture in their arm which helped.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Paraesthesia
Clinical narrative: Tingling in the arms and fingers; Numbness; No strength in the arms; Cannot grip things; Soreness and redness in the arm; Rash at injection site; Felt like throwing up; This spontaneous case was reported by a consumer and describes the occurrence of NAUSEA (Felt like throwing up), PARAESTHESIA (Tingling in the arms and fingers), MYALGIA (Soreness and redness in the arm), HYPOAESTHESIA (Numbness) and ASTHENIA (No strength in the arms) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037K20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced NAUSEA (Felt like throwing up), PARAESTHESIA (Tingling in the arms and fingers), MYALGIA (Soreness and redness in the arm), HYPOAESTHESIA (Numbness), ASTHENIA (No strength in the arms), GRIP STRENGTH DECREASED (Cannot grip things) and INJECTION SITE RASH (Rash at injection site). The patient was treated with LORATADINE, PSEUDOEPHEDRINE HYDROCHLORIDE (BENADRYL 24 D) for Adverse event, at a dose of UNK dosage form. At the time of the report, NAUSEA (Felt like throwing up), PARAESTHESIA (Tingling in the arms and fingers), MYALGIA (Soreness and redness in the arm), HYPOAESTHESIA (Numbness), ASTHENIA (No strength in the arms), GRIP STRENGTH DECREASED (Cannot grip things) and INJECTION SITE RASH (Rash at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient received acupuncture in their arm which helped.